Life-cycle assessment framework for indoor emissions of synthetic nanoparticles

1. Anjilvel S, Asgharian B (1995) A Multiple-Path Model of Particle Deposition in the rat lung. Toxicol Sci 28:41–5010.1093/toxsci/28.1.41 ↗

2. Bachler G, von Goetz N, Hungerbuehler K (2013) A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomed 8:3365

3. Bare J (2002) TRACI: the tool for the reduction and assessment of chemical and other environmental impacts. J Indust Ecol 6:49–7810.1162/108819802766269539 ↗

4. Bartley D, Vincent JH (2011) Sampling conventions for estimating ultrafine and fine aerosol particle deposition in the human respiratory tract. Ann Occup Hyg 55:696–70910.1093/annhyg/mer037 ↗

5. Bekker C, Brouwer DH, Tielemans E, Pronk A (2013) Industrial production and professional application of manufactured nanomaterials-enabled end products in dutch industries: potential for exposure. Ann Occup Hyg 57:314–32710.1093/annhyg/mes072 ↗

6. Birch ME, Ku B-K, Evans DE, Ruda-Eberenz TA (2011) Exposure and emissions monitoring during carbon nanofiber production. Part I: elemental carbon and iron-soot aerosols. Ann Occup Hyg 55:mer73

7. Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR (2014) Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibr Toxicol 11:1810.1186/1743-8977-11-18 ↗

8. Brouwer D et al (2013) Workplace air measurements and likelihood of exposure to manufactured nano-objects, agglomerates, and aggregates. J Nanopart Res 15:1–1410.1007/s11051-013-2090-7 ↗

9. California Council on Science and Technology (2010) Nanotechnology in California

10. Cherrie JW, MacCalman L, Fransman W, Tielemans E, Tischer M, Van Tongeren M (2011) Revisiting the effect of room size and general ventilation on the relationship between near- and far-field air concentrations. Ann Occup Hyg 55(9):1006–101510.1093/annhyg/mer092 ↗

11. Cho W-S et al (2012) Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6:22–3510.3109/17435390.2011.552810 ↗

12. Colorado Nanotechnology Alliance (2013) Doing business in Colorado. http://www.coloradonanotechnology.org

13. Crist RM et al (2013) Common pitfalls in nanotechnology: lessons learned from NCI’s Nanotechnology Characterization Laboratory. Integr Biol 5:66–7310.1039/C2IB20117H ↗

14. David RM, Nasterlack M, Engel S, Conner PR (2011) Developing a registry of workers involved in nanotechnology: BASF experiences. J Occup Environ Med 53:S32–S3410.1097/JOM.0b013e31821ad73f ↗

15. Donaldson K, Poland CA (2013) Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol 24:724–73410.1016/j.copbio.2013.05.003 ↗

16. Donaldson K, Murphy FA, Duffin R, Poland CA (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:510.1186/1743-8977-7-5 ↗

17. Elihn K, Berg P, Lidén G (2011) Correlation between airborne particle concentrations in seven industrial plants and estimated respiratory tract deposition by number, mass and elemental composition. J Aerosol Sci 42:127–14110.1016/j.jaerosci.2010.12.003 ↗

18. European Commission (2012) Second regulatory review on nanomaterials COM/2012/0572 final

19. Frederick S (2013) Who is the nanotechnology economy? Obstacles and methods of identifying and estimates of U.S. nano firms and workers. In: Sustainable Nanotechnology Organization (SNO) conference, Santa Barbara (United States), 2013. Santa Barbara, CA

20. Gerritzen G, Huang LC, Killpack K, Mircheva M, Conti J (2006) A review of current practices in the nanotechnology industry - Phase two report: Survey of current practices in the nanotechnology workplace. Produced for the International Council on Nanotechnology by the University of California, Santa Barbara. Available on http://cohesion.rice.edu/centersandinst/icon/emplibrary/ICONNanotechSurvey_indexed_Full%20Reduced.pdf

21. German Federal Institute for Occupational Safety and Health (BAuA) (2008) Exposure to nanomaterials in Germany

22. Godish T, Spengler JD (1996) Relationship between ventilation and indoor air quality: a review. Indoor Air 6:135–14510.1111/j.1600-0668.1996.00010.x ↗

23. Goedkoop M, Heijungs R, Huijbregts M, Schryver AD, Struijs J, Zelm RV (2009) ReCiPe 2008—a life cycle impact assessment method which comprises harmonised category indicators at the midpoint and the endpoint level. Bilthoven (Netherlands)

24. Golsteijn L, Huizer D, Hauck M, van Zelm R, Huijbregts MAJ (2014) Including exposure variability in the life cycle impact assessment of indoor chemical emissions: the case of metal degreasing. Environ Int 71:36–4510.1016/j.envint.2014.06.003 ↗

25. Guinée JB, Heijungs R, Huppes G, Kleijn R, Koning A de, Oers L van, Wegener Sleeswijk A, Suh S, Udo de Haes HA, Bruijn H de, Duin R van, Huijbregts MAJ (2001) Handbook on Life Cycle Assessment: Operational Guide to the ISO Standards. Kluwer Academic Publishers

26. Hellweg S, Demou E, Bruzzi R, Meijer A, Rosenbaum RK, Huijbregts MAJ, McKone TE (2009) Integrating human indoor air pollutant exposure within life cycle impact assessment. Environ Sci Technol 43:1670–167910.1021/es8018176 ↗

27. Hinds WC (1999) Aerosol technology: properties, behavior, and measurement of airborne particles. Wiley, New York

28. Honnert B, Grzebyk M (2013) Manufactured nano-objects: an occupational survey in five industries in France. Ann Occup Hyg:met058

29. Huijbregts MAJ, Struijs J, Goedkoop M, Heijungs R, Jan Hendriks A, Van De Meent D (2005) Human population intake fractions and environmental fate factors of toxic pollutants in life cycle impact assessment. Chemosphere 61:1495–150410.1016/j.chemosphere.2005.04.046 ↗

30. Humbert S et al (2011) Intake fraction for particulate matter: recommendations for life cycle impact assessment. Environ Sci Technol 45:4808–481610.1021/es103563z ↗

31. International Commission on Radiological Protection (ICRP) (1994) Human respiratory tract model for radiological protection. Elsevier, Tarrytown

32. Johnston H et al (2013) Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol 43:1–2010.3109/10408444.2012.738187 ↗

33. Jolliet O, Margni M, Charles R, Humbert S, Payet J, Rebitzer G, Rosenbaum R (2003) IMPACT 2002+: a new life cycle impact assessment methodology. Int J LCA 8:324–33010.1007/BF02978505 ↗

34. Kreyling WG, Semmler-Behnke M, Takenaka S, Möller W (2012) Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc Chem Res 46:714–72210.1021/ar300043r ↗

35. Lai DY (2012) Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:1–1510.1002/wnan.162 ↗

36. Liao HY, Chung YT, Lai CH, Wang SL, Chiang HC, Li LA, Tsou TC, Li WF, Lee HL, Wu WT, Lin MH, Hsu JH, Ho JJ, Chen CJ, Shih TS, Lin CC, Liou SH (2013) Six-month follow-up study of health markers of nanomaterials among workers handling engineered nanomaterials. Nanotoxicol 8:100–11010.3109/17435390.2013.858793 ↗

37. Marvin HJP et al (2013) Exploring the development of a decision support system (DSS) to prioritize engineered nanoparticles for risk assessment. J Nanopart Res 15:1–13

38. Maynard AD (2003) Estimating aerosol surface area from number and mass concentration measurements. Ann Occup Hyg 47:123–14410.1093/annhyg/meg022 ↗

39. Meesters JAJ, Koelmans AA, Quik JTK, Hendriks AJ, Van De Meent D (2014) Multimedia modeling of engineered nanoparticles with simpleBox4nano: model definition and evaluation. Environ Sci Technol 48(10):5726–573610.1021/es500548h ↗

40. Mercer RR et al (2008) Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol 294:L87–L9710.1152/ajplung.00186.2007 ↗

41. National Institute for Occupational Safety and Health NIOSH (2011) NIOSH Current Intelligence Bulletin 63: occupational exposure to titanium dioxide

42. National Institute for Occupational Safety and Health NIOSH (2013) NIOSH Current Intelligence Bulletin 65: occupational exposure to carbon nanotubes and nanofibers

43. Oomen AG et al (2014) Concern-driven integrated approaches to nanomaterial testing and assessment—report of the NanoSafety Cluster Working Group 10. Nanotoxicology 8:334–34810.3109/17435390.2013.802387 ↗

44. Pennington D, Crettaz P, Tauxe A, Rhomberg L, Brand K, Jolliet O (2002) Assessing human health response in life cycle assessment using ED10s and DALYs: part 2—Noncancer effects. Risk Anal 22:947–96310.1111/1539-6924.00263 ↗

45. Rejman J, Oberle V, Zuhorn I, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin and caveolae-mediated endocytosis. Biochem J 377:159–16910.1042/bj20031253 ↗

46. Rosenbaum R et al (2008) USEtox—the UNEP-SETAC toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment. Int J LCA 13:532–54610.1007/s11367-008-0038-4 ↗

47. Rosenbaum RK, Margni M, Jolliet O (2007) A flexible matrix algebra framework for the multimedia multipathway modeling of emission to impacts. Environ Int 33:624–63410.1016/j.envint.2007.01.004 ↗

48. Sargent LM et al (2014) Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 11:310.1186/1743-8977-11-3 ↗

49. Schmid K, Danuser B, Riediker M (2010) Nanoparticle usage and protection measures in the Manufacturing Industry—A Representative Survey. J Occup Environ Hyg 7:224–23210.1080/15459621003609127 ↗

50. Schneider T et al (2011) Conceptual model for assessment of inhalation exposure to manufactured nanoparticles. J Expo Sci Environ Epidemiol 21:450–46310.1038/jes.2011.4 ↗

51. Schubauer-Berigan MK, Dahm MM, Yencken MS (2011) Engineered carbonaceous nanomaterials manufacturers in the United States: workforce size, characteristics, and feasibility of epidemiologic studies. J Occup Environ Med 53:S62–S6710.1097/JOM.0b013e31821b1e2c ↗

52. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2010) Scientific basis for the definition of the term “Nanomaterial”. SCENIHR, Brussels

53. Solomon P et al (2012) Macroscopic to microscopic scales of particle dosimetry: from source to fate in the body. Air Qual Atmos Health 5:169–18710.1007/s11869-011-0167-y ↗

54. Stone V et al (2014) ITS-NANO-Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy Part Fibr Toxicol 11:9

55. Sung JH et al (2008) Lung Function Changes in Sprague-Dawley Rats After Prolonged Inhalation Exposure to Silver Nanoparticles. Inhal Toxicol 20:567–57410.1080/08958370701874671 ↗

56. US Environmental Protection Agency (2009) Integrated science assessment for particulate matter (Final Report). Washington, DC

57. van Zelm R et al (2008) European characterization factors for human health damage of PM10 and ozone in life cycle impact assessment. Atmos Environ 42:441–45310.1016/j.atmosenv.2007.09.072 ↗

58. Walser T, Hellweg S, Juraske R, Luechinger NA, Wang J, Fierz M (2012) Exposure to engineered nanoparticles: Model and measurements for accident situations in laboratories Sci Tot Env 42010.1016/j.scitotenv.2012.01.038 ↗

59. Wenger Y, Li D, Jolliet O (2012) Indoor intake fraction considering surface sorption of air organic compounds for life cycle assessment. Int J LCA 17:919–93110.1007/s11367-012-0420-0 ↗